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Metformin Induced Lactic Acidosis
Saad Chaudhry MD, Michael Ramalia, OMS4, Alan Mundakkal OMS4, Tony Singh,
OMS4, Omokayode Osobamiro MD

Henry Ford Health System, Detroit, Michigan
Background
Metformin induced lactic acidosis is an uncommon but potential severe
toxicity resulting from excess metformin accumulation in the setting of renal
failure or hepatic impairment. The lactic acidosis caused by metformin is
believed to be due in large part from inhibition of gluconeogenesis within the
liver resulting in lactic acid accumulation. Typically, lactic acid accumulation
is mitigated through the activities of the kidneys and liver through clearance
and metabolism, respectively. However, impairment of these systems can
result in metformin accumulation and profound acidosis. This patient’s
presentation with altered mental status, hypotension, and lactic acidosis
represents a lengthy differential necessitating extensive investigation.
Ultimately in the setting of metformin use, significant renal impairment, and a
severely elevated metformin level on analysis a diagnosis of metformin
induced lactic acidosis was reached. Although metformin is a very well
tolerated medication in the management of type 2 diabetes, metformin
induced lactic acidosis is a potentially major complication especially with
progressive or acutely arising disease.

Case
A 61 year old male with a history of type 2 diabetes mellitus on
metformin, prior CVA with residual left sided weakness, CKD, and HTN
on losartan was admitted for lethargy with symptoms that appear to have
began three days prior to presentation per discussion with family. On
presentation he was afebrile, hypotensive and experiencing an altered
mental status. He was immediately intubated for airway protection and a
significant metabolic acidosis was present on blood gases. Urine drug
screen was negative and imaging of the head, chest, abdomen and pelvis
were unremarkable except for evidence of prior cerebral infarct. The
patient was subsequently started on IV ceftriaxone, vancomycin, and
ampicillin for suspected meningitis and was started on hemodialysis due to
oliguria. Blood cultures were positive for enterococcus and antibiotics
were later de-escalated to IV ampicillin while lactic acid levels continued
to rise. Patient was evaluated with EEG without findings of seizure
activity. Over the course of hospitalization, patient’s mental status
improved and could minimally cooperate with elements of exam.
However, towards the end of his hospital course, family had elected to
withdraw care due to progressive clinical decline.

Inciting Events
1. Chronic Kidney Disease
2. Infection
3. Losartan Use
4. Progression to Septic Shock
5. Hypoxemia and Hypotension
6. Heart failure
7. Acute Kidney Injury superimposed over CKD

Clinical Features/Treatment
•
•
•
•
•
•
•
•

Nausea
Vomiting
Diarrhea
Altered Mental Status
Dyspnea
Hypotension
Tachycardia
Tachypnea

Conclusion

• Characterized by high lactate levels in the setting of metformin usage
• Anion gap metabolic acidosis
• Acidosis is often severe with a pH <7

• Prompt discontinuation of metformin
• Hemodialysis is generally regarded as the most efficacious approach to
correcting a severe metformin induced lactic acidosis
• Managing contributing condition

Photos

Altered mental status with significant metabolic acidosis in the
setting of acute kidney injury creates a significant differential
diagnosis that was further confounded by various overlapping
features. The patient’s case is presumed to have arise as a result
of bacterial infection with concurrent usage of losartan causing
an acute kidney injury superimposed on chronic kidney disease
allowing for toxic levels of metformin accumulation. Lactic acid
can be generally thought as type A due to tissue hypoperfusion
such as from sepsis or type B without hypo perfusion with
causes including metformin, malignancy, and alcohol. This
patient’s case is thought to have favored both type A and type B.
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Metformin
• Diabetes affects approximately 9.4% of individuals in the United States
• Metformin being the first line pharmaceutical treatment of type II diabetes
has meant its near ubiquitous presence
• Metformin’s has an excellent safety profile with reasonable efficacy
• Prevalence of Metformin induced lactic acidosis has been found to be less
then 10 cases per 100,000 patients
• Contraindications to metformin include eGFR less then 30 mL/ 1.73 m
squared
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